-transparent.png){kind=logo}
A patient with a somatostatin (SRIH)-secreting islet cell tumor, whose only symptoms were dyspepsia and anemia, is described. The diagnosis of somatostatinoma was based on high plasma SRIH concentrations and immunocytochemical findings. The pancreatic exocrine response to secretin was decreased, whereas the insulin and/or glucagon responses to glucose and arginine were normal. Although the basal plasma GH concentration was normal, the plasma GH response to GHRH was subnormal. Gel permeation chromatography studies indicated that SRIH-14 was the predominant form of SRIH in plasma as well as in tumor tissue.
Related Publications
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
March 1989,
The Journal of clinical endocrinology and metabolism,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
April 1987,
Endocrinology,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
May 1995,
The Journal of clinical endocrinology and metabolism,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
February 1994,
Endocrinology,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
January 1999,
Neuroendocrinology,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
April 1996,
The Journal of clinical endocrinology and metabolism,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
October 1998,
The Journal of clinical endocrinology and metabolism,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
May 1988,
Endocrinology,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
December 1988,
The Journal of endocrinology,
H Iguchi, and
S Kumagai, and
I H Seo, and
H Wakasugi, and
Y Hara, and
M Abe
November 1986,
Endocrinology,
